Georgia Senate Bill SB314

Georgia 2025-2026 Regular Session

• Introduced: 2/28/25
• Refer: 3/3/25

Caption

"Wholesale Prescription Drug Importation Act"; enact

Impact

If enacted, SB314 is expected to amend Title 31 of the Official Code of Georgia Annotated, establishing a framework for a wholesale prescription drug importation program. It mandates the formation of a division within the Department of Community Health tasked with overseeing this program. Importantly, the bill also includes provisions for the development of a registration process for health benefit plans, healthcare providers, and pharmacies wishing to participate, creating a clear pathway for stakeholders to engage with the system.

Summary

Senate Bill 314, known as the 'Wholesale Prescription Drug Importation Act,' aims to establish a comprehensive program that allows the importation of prescription drugs from Canada to Georgia. The primary intent of this legislation is to enhance access to affordable medications, addressing a critical public health issue faced by many Georgians who struggle with the high costs of prescription drugs. The bill outlines the necessary procedures for implementing such a program, emphasizing that the drugs must meet strict safety and efficacy standards set by the FDA, and aims to generate significant cost savings for consumers, health benefit plans, and employers alike.

Contention

There are notable points of contention surrounding this legislation. Critics may raise concerns about the potential for regulatory challenges, particularly the necessity for compliance with both federal and state regulations governing the importation of drugs. Additionally, issues regarding the reliability of Canadian suppliers and the risks of introducing imported medications into the local market may be highlighted. The bill also establishes that its implementation is contingent upon the appropriation of funds, which could affect its eventual execution and impact.